The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...
2h
Hosted on MSNDon't hesitate to go to hospital if with symptoms amid rise in dengue cases —expertAs dengue cases rise, an infectious disease expert on Sunday reminded the public not to hesitate to go to the hospital if ...
Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the ...
1d
News Medical on MSNNIH-Funded Clinical Trial will Evaluate New Dengue TherapeuticIf AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
The Mayor of Quezon City, the most populous city in the capital region of the Philippines, declared a dengue outbreak on ...
Researchers, led by those from Korea Advanced Institute of Science and Technology and the Institute for Basic Science, ...
Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...
Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results